These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18428565)

  • 1. Analyzing radioligand binding data.
    Motulsky H; Neubig R
    Curr Protoc Neurosci; 2002 Aug; Chapter 7():Unit 7.5. PubMed ID: 18428565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing radioligand binding data.
    Motulsky H; Neubig R
    Curr Protoc Protein Sci; 2001 May; Appendix 3():Appendix 3H. PubMed ID: 18429075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical aspects of radioligand binding.
    McKinney M; Raddatz R
    Curr Protoc Pharmacol; 2006 Jul; Chapter 1():Unit1.3. PubMed ID: 22294165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing binding data.
    Motulsky HJ; Neubig RR
    Curr Protoc Neurosci; 2010 Jul; Chapter 7():Unit 7.5. PubMed ID: 20578035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor binding techniques.
    Frey KA; Albin RL
    Curr Protoc Neurosci; 2001 May; Chapter 1():Unit1.4. PubMed ID: 18428450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioligand binding assays and their analysis.
    Maguire JJ; Kuc RE; Davenport AP
    Methods Mol Biol; 2012; 897():31-77. PubMed ID: 22674160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays.
    Leach K; Sexton PM; Christopoulos A
    Curr Protoc Pharmacol; 2011 Mar; Chapter 1():Unit 1.22. PubMed ID: 21935902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saturation assays of radioligand binding to receptors and their allosteric modulatory sites.
    Basile A
    Curr Protoc Neurosci; 2001 May; Chapter 7():Unit7.6. PubMed ID: 18428532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of an iodinated radioligand.
    True CD
    Curr Protoc Neurosci; 2001 May; Appendix 3():Appendix 3A. PubMed ID: 18428448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
    Barrondo S; Sallés J
    Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental strategies for studying G protein-coupled receptor homo- and heteromerization with radioligand binding and signal transduction methods.
    Maggio R; Rocchi C; Scarselli M
    Methods Enzymol; 2013; 521():295-310. PubMed ID: 23351746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of calcium channel binding.
    Zheng W
    Curr Protoc Pharmacol; 2001 Nov; Chapter 1():Unit1.25. PubMed ID: 21959753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioligand-binding methods for membrane preparations and intact cells.
    Bylund DB; Deupree JD; Toews ML
    Methods Mol Biol; 2004; 259():1-28. PubMed ID: 15250483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
    Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
    Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
    Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
    J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining allosteric modulator mechanism of action: integration of radioligand binding and functional assay data.
    Langmead CJ
    Methods Mol Biol; 2011; 746():195-209. PubMed ID: 21607858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays.
    Rogines-Velo MP; Pelorosso FG; Zold CL; Nowak W; Pesce GO; Sardi SP; Brodsky PT; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):587-95. PubMed ID: 12444501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.